Conditas will represent the Melbourne and Shanghai based company as its agent for business development and sales of services in the US.
The Conditas Group Jr. founder and principal Leland L Johnson said they would benefit from SYN|thesis by receiving efficient and cost-effective synthetic chemistry resources, besides receiving medicinal chemistry and drug discovery services.
"This new partnership broadens our offerings across the biology and chemistry spectrum and allows us to give our customers a more expansive suite of services," Johnson added.